The Technical Analyst
Select Language :
Aerovate Therapeutics, [AVTE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Aerovate Therapeutics, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Aerovate Therapeutics, is listed at the  Exchange

3.75% $29.57

America/New_York / 28 mar 2024 @ 16:00


Aerovate Therapeutics,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 823.91 mill
EPS: -2.87
P/E: -10.30
Earnings Date: May 12, 2024
SharesOutstanding: 27.86 mill
Avg Daily Volume: 0.118 mill
RATING 2024-03-28
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -10.30 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-1.75x
Company: PE -10.30 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.866
(-97.07%) $-28.70
Date: 2024-03-29
Expected Trading Range (DAY)

$ 27.56 - 31.76

( +/- 7.07%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-27 Dake Benjamin T Sell 11 068 Stock Option (Right to Buy)
2024-03-27 Dake Benjamin T Buy 11 068 Common Stock
2024-03-27 Dake Benjamin T Sell 11 068 Common Stock
2024-03-25 Dake Benjamin T Sell 3 432 Stock Option (Right to Buy)
2024-03-25 Dake Benjamin T Buy 3 432 Common Stock
INSIDER POWER
45.55
Last 100 transactions
Buy: 747 762 | Sell: 268 911

Forecast: 16:00 - $29.73

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $29.73
Forecast 2: 16:00 - $29.73
Forecast 3: 16:00 - $29.73
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $29.57 (3.75% )
Volume 0.215 mill
Avg. Vol. 0.118 mill
% of Avg. Vol 182.77 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Aerovate Therapeutics, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Aerovate Therapeutics, Inc.

RSI

Intraday RSI14 chart for Aerovate Therapeutics, Inc.

Last 10 Buy & Sell Signals For AVTE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:30buy$20.81N/AActive
Profile picture for
            Aerovate Therapeutics, Inc.

AVTE

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Last 10 Buy Signals

Date Signal @
SKLUSDMar 29 - 10:37$0.130
HTUSDMar 29 - 10:34$0.905
PROUSDMar 29 - 10:30$2.05
BORAUSDMar 29 - 10:30$0.229
WAVESUSDMar 29 - 10:28$3.94
XMRUSDMar 29 - 10:28$134.00
YAKUSDMar 29 - 10:23822.65
STXUSDMar 29 - 10:23$3.58
AUCTIONUSDMar 29 - 10:2326.67
RIOUSDMar 29 - 10:192.44

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.